Autonomix Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMIX research report →
Price Chart
About the company
Autonomix Medical, Inc. , a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
- CEO
- Bradley A. Hauser
- IPO
- 2024
- Employees
- 10
- HQ
- The Woodlands, TX, US
Get TickerSpark's AI analysis on AMIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $484.14K
- P/E
- -0.05
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.19
- EV/EBITDA
- 0.60
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -191.88%
- ROIC
- -173.27%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-12,000+0.0%
- Op Income
- $-17,034,000
- Net Income
- $-16,715,000-46.5%
- EPS
- $-48.64+64.1%
- OCF Growth
- -48.7%
- FCF Growth
- -48.6%
- 52W High
- $24.68
- 52W Low
- $0.88
- 50D MA
- $2.79
- 200D MA
- $6.25
- Beta
- -1.30
- RSI (14)
- 21
- Avg Volume
- 2.01M
No earnings-call transcripts are available for AMIX yet.
- Free Float
- 96.9%
- Shares Outstanding
- 543.30K
- Float Shares
- 526.44K
of shares held by institutions
7 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Mariner, LLC | 50.14K | 0 |
| Geode Capital Management, LLC | 48.64K | ▲ 48.64K |
| Jane Street Group, LLC | 46.74K | ▲ 46.74K |
| Tower Research Capital LLC (Trc) | 800 | ▲ 487 |
| Allied Private Wealth LLC | 347 | ▲ 347 |
| Osaic Holdings, Inc. | 250 | ▲ 250 |
| Pnc Financial Services Group, Inc. | 75 | 0 |
| Caitong International Asset Management Co., Ltd | 23 | ▲ 23 |
| Mercer Global Advisors Inc /Adv | 2 | ▲ 2 |
| Citigroup Inc | 1 | ▲ 1 |
| Jpmorgan Chase & Co | 1 | ▲ 1 |
| Networth Advisors, LLC | 1 | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 14, 26 | Kalter Sandra C | other | 0 |
| Sep 3, 26 | Smith Trent N. | other | 15,000 |
| Sep 3, 26 | KLEMP WALTER V | other | 13,000 |
| Sep 3, 26 | Bisson Lori | other | 13,000 |
| Sep 3, 26 | Hauser Bradley | other | 27,000 |
| Aug 11, 25 | Hauser Bradley | sell | 45,000 |
| Aug 11, 25 | Capelli Christopher | sell | 3,750 |
| Aug 11, 25 | KLEMP WALTER V | sell | 8,773 |
| Aug 11, 25 | Bisson Lori | sell | 18,862 |
| Aug 11, 25 | Bisson Lori | sell | 46,680 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMIX coverage
Recent articles, reports, and earnings notes.
No research on AMIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMIX report →Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026
globenewswire.com · Nov 12
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
globenewswire.com · Nov 10
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
globenewswire.com · Oct 2
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
globenewswire.com · Sep 30
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
globenewswire.com · Sep 24
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
globenewswire.com · Sep 16
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
globenewswire.com · Sep 1
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
globenewswire.com · Aug 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.